BLIS Technologies Limited logo

Revenue growth with one off cost pressures impacting profit

Operational Update17 August 2025BLTConsumer Staples

BLIS Technologies Limited
399 Moray Place, Dunedin, New Zealand, 9016

blis.co.nz

info@blis.co.nz

18 August 2025


Revenue growth with one off cost pressures impacting profitability


BLIS Technologies Limited (BLIS) delivers revenue of $3.5m for the first quarter ending 30 June

2025 (1Q26), an increase of $0.1m on the same period last year. 1Q26 EBITDA is a $0.2m loss

compared to a $0.5m profit for 1Q25.


1Q26 results are characterised by growth in Private Label revenues and strong New Zealand

wholesale revenues leading into winter. Total ingredient revenues were down compared to the

same period last year, impacted by the timing of orders for one of our larger customers, but will

rebound this quarter.


1Q26 earnings have been impacted by one-off cost increases within the supply chain. The one-

off cost increase is forecast to be $0.9m in the full year FY26 with $0.7m impacting the Q1

result. Q1 EBITDA is a $0.5m profit on an underlying basis excluding one-off costs (Q1 2025

$0.5m).


“Based on current market indicators, we are forecasting revenue in 1HY26 will be around

$7.5m, driven by a strengthening of ingredient revenues. This represents an increase of 25%

from 1HY25. EBITDA (inclusive of one-off costs) for 1HY26 is expected to be a profit slightly

below the same period last year (1HY25 $0.3m).


“The timing of ingredient sales and the one-off costs in the supply chain have impacted the Q1

result. An improved Q2 result will offset the lower Q1 trading result. At this stage we are

forecasting revenue growth of between 10% and 15% for the full year FY26” said Scott

Johnson, CEO.


Ends


For further information, please contact:


Scott Johnson

CEO

+64 21 488 831



About BLIS Technologies Ltd


Delivering proven health benefits through evidence-based, advanced probiotics

BLIS Technologies is an NZX-listed manufacturer of advanced probiotic strains that go beyond the gut.

Combining innovation with evidence-based research and the highest quality production controls enables

the delivery of probiotic solutions for specific health targets including throat health, halitosis (bad breath),

immune support, teeth and gum health and skin health. BLIS

®

products are sold throughout New Zealand

and in Asia, Europe and the USA. More information about BLIS Technologies Ltd can be found at

www.blis.co.nz.




BLIS Technologies Limited

399 Moray Place, Dunedin, New Zealand, 9016

blis.co.nz

info@blis.co.nz


Website: www.blis.co.nz

Instagram: @blisprobiotics #blisk12 #blism18 #blisq24

Facebook: @BLISProbiotics

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.